Product Information
ENALAPRIL-HYDROCHLOROTHIAZIDE 10-25 MG TABLET is a generic product labeled by Taro Pharmaceuticals U.S.A. Inc., priced at $0.1786 per EA under NDC 51672404601. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Sep 18, 2001. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10; 25 mg/1; mg/1
Manufacturer
Taro Pharmaceuticals U.S.A. Inc.NDC
51672404601
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ENALAPRIL MALEATE; HYDROCHLOROTHIAZIDEApproval Type
Generic (ANDA)
FDA Application
ANDA075788FDA Approved
9/18/2001
TE Code
AB
On Market Since
9/18/2001
Pharmacological Classes
Price Statistics
The NADAC for ENALAPRIL-HYDROCHLOROTHIAZIDE 10-25 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 102.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1786 per EA |
|---|---|
| All-time high | $0.2921 (Mar 13, 2019) |
| All-time low | $0.0852 (Jul 23, 2014) |
| 52-week high | $0.1907 |
| 52-week low | $0.1540 |
| Median price | $0.1623 |
| Average price | $0.1665 |
| Largest weekly change | +82.1% (Dec 19, 2018) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Enalapril Maleate and Hydrochlorothiazide market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ENALAPRIL-HYDROCHLOROTHIAZIDE 10-25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ENALAPRIL-HYDROCHLOROTHIAZIDE 10-25 MG TABLET, manufactured by Taro Pharmaceuticals U.S.A. Inc., is $0.1786 per EA (NDC 51672404601), effective Aug 19, 2026.
How has the price of ENALAPRIL-HYDROCHLOROTHIAZIDE 10-25 MG TABLET changed over time?
Over the history we have for it, the NADAC for ENALAPRIL-HYDROCHLOROTHIAZIDE 10-25 MG TABLET has risen 102.4%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ENALAPRIL-HYDROCHLOROTHIAZIDE 10-25 MG TABLET?
Since Nov 28, 2013, the NADAC for ENALAPRIL-HYDROCHLOROTHIAZIDE 10-25 MG TABLET has ranged from a low of $0.0852 (Jul 23, 2014) to a high of $0.2921 (Mar 13, 2019), with a median of $0.1623 per EA.
Are there cheaper alternatives to ENALAPRIL-HYDROCHLOROTHIAZIDE 10-25 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of ENALAPRIL-HYDROCHLOROTHIAZIDE 10-25 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ENALAPRIL-HYDROCHLOROTHIAZIDE 10-25 MG TABLET?
ENALAPRIL-HYDROCHLOROTHIAZIDE 10-25 MG TABLET (NDC 51672404601) is labeled by Taro Pharmaceuticals U.S.A. Inc., and CMS classifies it as a generic product.